
Indoco Remedies Limited has informed the Exchange regarding a press release dated August 27, 2021, titled "INDOCO'S CLINICAL RESEARCH ORGANIZATION- ANACIPHER RECEIVES ACCREDITATION FROM UKMHRA".
Filed with NSE ·

Indoco Remedies Limited has informed the Exchange regarding a press release dated August 27, 2021, titled "INDOCO'S CLINICAL RESEARCH ORGANIZATION- ANACIPHER RECEIVES ACCREDITATION FROM UKMHRA".
6ix hasn’t read this filing yet.
Indoco Remedies Limited on 6ix
Follow Indoco Remedies into a list and get an email when it puts out news.
Follow Indoco Remedies